as 12-18-2024 4:00pm EST
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
Founded: | N/A | Country: | Canada |
Employees: | N/A | City: | TORONTO |
Market Cap: | 2.2M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 418.6K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -7.97 | EPS Growth: | N/A |
52 Week Low/High: | $0.28 - $2.21 | Next Earning Date: | 11-13-2024 |
Revenue: | $67,200,000 | Revenue Growth: | -18.55% |
Revenue Growth (this year): | -11.49% | Revenue Growth (next year): | 4.39% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Natale Anthony | VERO | Director | Dec 3 '24 | Sell | $0.31 | 42,768 | $13,193.93 | 0 | |
Masters Michael Willingham | VERO | 10% Owner | Oct 3 '24 | Sell | $0.53 | 162,896 | $85,552.98 | 184,122 | |
Masters Michael Willingham | VERO | 10% Owner | Sep 30 '24 | Sell | $0.59 | 306,135 | $179,640.96 | 184,122 |
VERO Breaking Stock News: Dive into VERO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GuruFocus.com
2 months ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
GlobeNewswire
4 months ago
GlobeNewswire
5 months ago
The information presented on this page, "VERO Venus Concept Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.